No abstract available
MeSH terms
-
Anemia, Refractory, with Excess of Blasts / chemically induced
-
Anemia, Refractory, with Excess of Blasts / drug therapy
-
Anemia, Refractory, with Excess of Blasts / etiology*
-
Anemia, Refractory, with Excess of Blasts / genetics
-
Aneuploidy
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Asparaginase / administration & dosage
-
Asparaginase / adverse effects
-
Child
-
Chromosome Aberrations*
-
Chromosomes, Human, Pair 8 / genetics*
-
Cladribine / administration & dosage
-
Combined Modality Therapy
-
Cranial Irradiation / adverse effects*
-
Cytarabine / administration & dosage
-
Cytarabine / adverse effects
-
Daunorubicin / administration & dosage
-
Daunorubicin / adverse effects
-
Fatal Outcome
-
Female
-
Gene Amplification*
-
Genes, myc*
-
Humans
-
Hydrocortisone / administration & dosage
-
Hydrocortisone / adverse effects
-
Karyotyping
-
Mercaptopurine / administration & dosage
-
Mercaptopurine / adverse effects
-
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
-
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / radiotherapy
-
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / therapy*
-
Prednisone / administration & dosage
-
Prednisone / adverse effects
-
Vincristine / administration & dosage
-
Vincristine / adverse effects
Substances
-
Cytarabine
-
Cladribine
-
Vincristine
-
Mercaptopurine
-
Asparaginase
-
Prednisone
-
Hydrocortisone
-
Daunorubicin